December 7, 2009
CASE CCC IN THE NEWS
Friend to Friend: University Hospitals Breast Cancer Vaccine Study
Brain Tumor Cells Made More Responsive to Radiation
Li Li, MD, PhD and Nathan Berger, MD were featured participants in the Fourth International Symposium on Community Health and Family Medicine in Shanghai, Zhabei, on November 11. The fourth in a series, the conference focused on changing and improving health and health management in Zhabei District Shanghai, which has a population of over 1.1 million residents. Please click here to read more.
ASH PRESENTATIONS- Case CCC Members
The American Society of Hematology (ASH) Annual Meeting began December 5 and runs through December 8 in New Orleans. The Cancer Center is pleased to have many members participating: Education Programs and Oral Sessions and Posters. Please support your colleagues if you are attending the meeting. Congratulations to everyone!
NEW FLUORESCENCE MOLECULAR TOMOGRAPHY (FMT) INSTRUMENT
The Case CCC recently purchased a Fluorescence Molecular Tomography (FMT) instrument that is available for use in the Case Center for Imaging Research. This second generation fluorescence imaging device uses tomography to detect and quantify fluorescence from anywhere within the body of a mouse. It is extremely sensitive and has equal to or greater resolution than microPET imaging devices, i.e. approximately 1-2 mm resolution. The instrument is able to detect wavelengths compatible with currently used fluorophores, making adaptation to ongoing fluorescent studies seamless.
The device is essentially an in vivo small animal imaging system that has great applicability to preclinical research use. It is designed to provide calibrated quantitative tomographic images and data of fluorescence signals within biological tissue through the depth of the subject. Ongoing studies such as stem cell tracking benefit from the quantitative tools provided by this system, which are far more precise than those previously available.
A training seminar on this device is scheduled for Tuesday, December 8 at 12:00 pm in Wearn B-37, and is sponsored by the NFCR Center for Molecular Imaging at Case. Representatives from VisEn Instruments, the machine's manufacturer, will present on Fluorescence Molecular Tomography: Quantitating Biology to the pmol. Lunch will be served. Case CCC members are urged to attend. Please contact Gopi Ramamurthy, PhD with any questions.
MARK YOUR CALENDARS– Case CCC Scientific Series: TREC
Please mark your calendars for the next installment of the Case CCC Scientific Series and reception on January 28, 2010 from 4:00 pm-7:00 pm in Wolstein Auditorium (WRB 1413). Presentations will be related to the Case Transdisciplinary Research on Energetics and Cancer (TREC) Center, led by Dr. Nathan Berger:
•Stephanie Doerner: Diet, Obesity and Susceptibility to Colon Cancer
Everyone is welcome and encouraged to attend.
MARK YOUR CALENDARS– Weekly Seminar Series on Applied Biostatistics in Clinical Research
Dr. Mark Schluchter will be teaching a free nine-week course on applied biostatistics in clinical research. The course, which is sponsored by the William T. Dahms Clinical Research Unit and the CTSC, will be held Thursdays from 4:00 pm - 5:30 pm in SOM E501 starting January 14, 2010.
The course is targeted toward faculty, fellows, and others involved in clinical research at CWRU and its affiliated hospitals, and is meant to provide an introductory overview. Emphasis is non-mathematical, focusing on understanding what methods to use in what situations, and on how to interpret the results. This is a non-credit course with no formal examination. Individuals are welcome to attend some or all lectures depending on their particular interest.
To register online, please click here.
NCI CANCER BULLETIN– Special Issue: Cancer Research Training
Cancer Research Highlights
FUNDING OPPORTUNITY– American Institute for Cancer Research
The American Institute for Cancer Research (AICR) recently released their updated grant application package. Applications are being accepted for the following grants:
Application Deadline: February 19, 2010
For details, please click here.
FUNDING OPPORTUNITY– Damon Runyon Cancer Research Foundation Clinical Investigator Award
CWRU SOM has been invited to nominate up to three individuals for the Damon Runyon Cancer Research Foundation Clinical Investigator Award. This award supports young physician-scientists conducting patient-oriented cancer research, with a goal of increasing the number of physicians capable of moving seamlessly between the laboratory and the patient's bedside in search of breakthrough treatments.
If you are interested in being nominated for this award, please send your biosketch to firstname.lastname@example.org. External application deadline is March 1, 2010.
For details, please click here.
**All events are open to anyone interested in attending
Hem/Onc Research in Progress Seminar cancelled
Pathology Research Seminar
Sequencing Data Interest Group (SDIG)
Physiology & Biophysics Seminar
Skeletal Research Center Seminar
Fluorescence Molecular Tomography (FMT) Training Seminar
Inflammation, Infection and Cancer Focus Group Meeting
Genetics and Proteomics Seminar
Pathology Special Seminar
Molecular Genetics Seminar
Taussig Cancer Institute Core Curriculum Series
Physiology and Biophysics Seminar
Hematology/ Oncology Fellows Conference
Cell Biology Seminar
Cancer Center Seminar Series/ Blood Club
UPCOMING CANCER CENTER SYMPOSIUMS & EVENTS
Case CCC Core Facility Fair
Case CCC Scientific Series- TREC
Case CCC Scientific Retreat
ADDITIONAL UPCOMING SEMINARS & EVENTS
32nd Annual CTRC-AACR San Antonio Breast Cancer Symposium
AACR Seminar: Genetics and Biology of Brain Cancers
Radiological Society of North America (RSNA) Clinical Trials Methodology Workshop
AACR-IASLC Joint Conference on Molecular Origins of Lung Cancer: Prospects for Personalized Prevention and Therapy
AACR-JCA 8th Joint Conference on Cancer Genomics, Epigenomics, and the Development of Novel Therapeutics
AACR 101st Annual Meeting
CALL FOR NOMINATIONS– FDA-ODAC Call for Nominations 2010
The Food and Drug Administration (FDA) is requesting nominations for members to serve on the Oncologic Drugs Advisory Committee (ODAC) in the Center for Drug Evaluation and Research (CDER). The ODAC is a standing committee that reviews and evaluates data concerning the safety and effectiveness of marketed and investigational human drug products for use in the treatment of cancer and formulates recommendations to the FDA. Committee members generally serve terms of four years and are selected from authorities knowledgeable in general oncology, pediatric oncology, hematologic oncology, tumor immunology, biostatistics, and other related specialties. Candidates should have familiarity and experience in the conduct and interpretation of clinical trials. Candidates should also have minimal conflicts of interest.
The FDA will be accepting recommendations for ODAC members through December 23. Please forward CVs of candidates to Nicole Vesely, PharmD, Designated Federal Official for the ODAC. CVs must contain candidate contact information, including phone number and email address. Click here to view Dr. Vesely's contact information.
FACULTY CANDIDATE SEARCH– Associate Director for Basic Research
The Case CCC is currently accepting applications for the position of Associate Director for Basic Research. As we continue our search, we ask that people in the Cancer Center community encourage any qualified candidate to apply for the position. If you would like to nominate someone for the position, please contact Tracy Rehl (email@example.com).
Click here to view the job description.
ADOPT A FAMILY
In the spirit of the holidays, the Case CCC is sponsoring two families in need.
The first family consists of a mother, father and two boys, ages 9 and 11. The father was diagnosed with melanoma several years ago, and was recently diagnosed with lymphoma. Co-pays have piled up from tests and doctors' appointments. The patient has developed foot neuropathy that makes it difficult for him to work at his job that requires long periods of standing. Also, he will not be able to work much while he is undergoing chemotherapy. The family has provided a small wish list of items; gift cards and cash are also greatly appreciated.
We are also adopting the family of a former Cancer Center employee who died of cancer in November. To view the family wish list, please click here. Gift cards and cash are greatly appreciated.
Please turn in all donations to Gillian Todd (Wearn 149) by Monday, December 14.
Please email Gillian.firstname.lastname@example.org if you have any questions.
CASE CCC ON FACEBOOK AND LINKEDIN– Join Us!
We are always trying to foster communication and collaboration across the cancer center community any way that we can. The Case CCC has set up a page on Facebook and LinkedIn, so please become a fan of us on Facebook or join our group on LinkedIn, and encourage others to do so as well. Please help us spread the word.
We encourage you to post events, relevant news articles, items of discussion, etc… Your feedback is appreciated!
PREVIOUSLY ANNOUNCED FUNDING OPPORTUNITIES
AACR-AstraZeneca Fellowship for Translational Lung Cancer Research
DOD PRCRP Idea Awards
NIH Bulletin – Notices and Funding Opportunities
Gillian Irwin Todd
11100 Euclid Avenue, Wearn 149
Cleveland, Ohio 44106-5065
HELP US HELP YOU!
If you have a new grant, recently won an award, or have other newsworthy items, please let us know so we can publicize them in the newsletter and other media outlets. You deserve the accolades!
Send items to email@example.com.
|If you have trouble viewing this page, click here to view the newsletter online on our website.|